[1]
Yosipovitch, G. , Zeidler, C. , Apfelbacher, C.J. , Laquer, V. , Kim, B.S. , Casillas, M. , Pierce, E. , Chen, S. , Qiao, M. , Agell, H. and Del Rosso, J. 2023. Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s273. DOI:https://doi.org/10.25251/skin.7.supp.273.